TED Ted Baker Plc

RNS Number:2218R
Tepnel Life Sciences PLC
13 September 2005

13 September 2005

                    Tepnel Life Sciences plc ('the Company')

                               Holding in Company

The Company received notification on 13 September 2005 that, following recent
purchases, Mr. J M Harvey has a notifiable interest in 9,441,909 ordinary shares
of 1p each in the Company representing approximately 4.43 per cent of the issued
share capital.

About Tepnel

Tepnel Life Sciences (TLS) is a UK based international biotechnology company.
The Company has laboratories, manufacturing and operations in the USA, UK and
France with 175 employees.  TLS provides test kits, reagents and services to two
highly synergistic markets, these being Molecular Diagnostics and Biomedical
Research.  The company's strategy has been to identify high growth niche
opportunities within these multi-billion pound markets.  TLS focuses on these
niche opportunities with internally developed products, patents, expertise and
know-how as well as strategic acquisitions, to develop a leadership position
within these defined market segments.


Enquiries:

Ben Matzilevich, Chief Executive Officer, Tepnel Life Sciences plc 0161 946 2200
Gron Ffoulkes-Davies, Finance Director, Tepnel Life Sciences plc   0161 946 2200
Mark Percy, Seymour Pierce Limited                                 0207 107 8000
Richard Anderson, De Facto Communications Ltd                      0207 940 1000



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
HOLGUUWGBUPAGQW

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024